PGIM India Healthcare IDCW Payout Direct Plan
SIP amount
Min. ₹1,000
Lumpsum amount
Min. ₹5,000

PGIM India Healthcare IDCW Payout Direct Plan

NAV
₹10.0000
+0.70%
(17 Mar)
AUM
92 Cr
TER
0.65%
Risk
Very High Risk
Insights
Net Asset Value (NAV) is below its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+24.5%
+24.5%
+24.5%
+22.4%
+11.1%
3Y
+33.1%
+33.1%
+33.1%
+30.6%
NA
5Y
+27.0%
+27.0%
+27.0%
+25.2%
NA
ALL
+12.1%
+12.1%
+12.1%
+16.1%
NA
VOL
20.0%
20.0%
20.0%
20.1%
13.3%
TER
0.8%
0.8%
0.8%
0.9%
0.7%
AUM
₹6,545 Cr
₹6,545 Cr
₹6,545 Cr
₹1,511 Cr
₹92 Cr
INFO
0.60
0.60
0.60
0.80
0.00
See fund holdings as of 28th Feb
Top holdings
Sun Pharmaceuticals Industries Ltd
11.7%
Divi's Laboratories Ltd
10.3%
Aster DM Healthcare Ltd Ordinary Shares
7.1%
J.B. Chemicals & Pharmaceuticals Ltd
6.4%
Dr Reddy's Laboratories Ltd
6.1%
Max Healthcare Institute Ltd Ordinary Shares
5.8%
Rubicon Research Ltd
5.3%
Mankind Pharma Ltd
5.0%
Ajanta Pharma Ltd
4.9%
Krishna Institute of Medical Sciences Ltd
4.4%
Top industry exposure
Healthcare
92.2%
Basic Materials
2.8%
Financial Services
2.6%
Other information
Minimum SIP
₹1,000
Minimum lumpsum
₹5,000
Additional lumpsum
₹1,000
Portfolio turnover
21%
Lock-in period
-
Exit load
• 0.5% for redemption within 90 days
Fund objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns
Fund manager(s)
Puneet Pal
Anandha Padmanabhan Anjeneyan
Utsav Mehta
Vivek Sharma

FAQs